BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hua Q, Mi B, Huang G. The emerging co-regulatory role of long noncoding RNAs in epithelial-mesenchymal transition and the Warburg effect in aggressive tumors. Crit Rev Oncol Hematol 2018;126:112-20. [PMID: 29759552 DOI: 10.1016/j.critrevonc.2018.03.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Fedele M, Sgarra R, Battista S, Cerchia L, Manfioletti G. The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression. Int J Mol Sci 2022;23:800. [PMID: 35054987 DOI: 10.3390/ijms23020800] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
2 Xu F, Hua Q, Zhang A, Di Z, Wang Y, Zhao L, Yang H, Liu J, Huang G. LncRNA AC020978 facilitates non-small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway. Cancer Sci 2021;112:4501-14. [PMID: 34424600 DOI: 10.1111/cas.15116] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Cioce M, Pulito C, Strano S, Blandino G, Fazio VM. Metformin: Metabolic Rewiring Faces Tumor Heterogeneity. Cells 2020;9:E2439. [PMID: 33182253 DOI: 10.3390/cells9112439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
4 Huang X, Yang X, Sun C, Huang S, Cheng M, Han Y. Biophysical signal transduction in cancer cells: Understanding its role in cancer pathogenesis and treatment. Biochim Biophys Acta Rev Cancer 2020;1874:188402. [PMID: 32771535 DOI: 10.1016/j.bbcan.2020.188402] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Yin D, Hua L, Wang J, Liu Y, Li X. Long Non-Coding RNA DUXAP8 Facilitates Cell Viability, Migration, and Glycolysis in Non-Small-Cell Lung Cancer via Regulating HK2 and LDHA by Inhibition of miR-409-3p. Onco Targets Ther 2020;13:7111-23. [PMID: 32801745 DOI: 10.2147/OTT.S243542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhou S, Zhang M, Zhou C, Wang W, Yang H, Ye W. The role of epithelial-mesenchymal transition in regulating radioresistance. Crit Rev Oncol Hematol 2020;150:102961. [PMID: 32361589 DOI: 10.1016/j.critrevonc.2020.102961] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
7 Hua Q, Mi B, Xu F, Wen J, Zhao L, Liu J, Huang G. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis. Theranostics 2020;10:4762-78. [PMID: 32308748 DOI: 10.7150/thno.43839] [Cited by in Crossref: 64] [Cited by in F6Publishing: 73] [Article Influence: 32.0] [Reference Citation Analysis]
8 Guo Y, Liang F, Zhao F, Zhao J. Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer. Mol Cell Biochem 2020;466:103-15. [PMID: 32006291 DOI: 10.1007/s11010-020-03692-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
9 Zeng Z, Zhao G, Rao C, Hua G, Yang M, Miao X, Ying J, Nie L. Knockdown of lncRNA ZFAS1-suppressed non-small cell lung cancer progression via targeting the miR-150-5p/HMGA2 signaling. J Cell Biochem 2019. [PMID: 31692094 DOI: 10.1002/jcb.29542] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
10 Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L, Liu J, Huang G. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol 2019;12:91. [PMID: 31488218 DOI: 10.1186/s13045-019-0773-y] [Cited by in Crossref: 40] [Cited by in F6Publishing: 87] [Article Influence: 13.3] [Reference Citation Analysis]
11 Shan H, Zhou X, Chen C. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2. Mol Med Rep 2019;20:1459-67. [PMID: 31173203 DOI: 10.3892/mmr.2019.10325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Hu Q, Tai S, Wang J. Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers. Pathol Res Pract 2019;215:843-8. [PMID: 30723052 DOI: 10.1016/j.prp.2019.01.033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
13 Denaro N, Merlano MC, Lo Nigro C. Long noncoding RNAs as regulators of cancer immunity. Mol Oncol 2019;13:61-73. [PMID: 30499165 DOI: 10.1002/1878-0261.12413] [Cited by in Crossref: 34] [Cited by in F6Publishing: 75] [Article Influence: 8.5] [Reference Citation Analysis]